Vasculitis in Children

Rheumatic Disease Clinics of North America

Volumn 33, Issue 3, 2007, Pages 555-583

  Dedeoglu, Fatma ^a,b   Sundel, Robert P ^a,b  

^a Division of Immunology   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ACUTE PHASE PROTEIN; AZATHIOPRINE; C REACTIVE PROTEIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DIPYRIDAMOLE; IMMUNOGLOBULIN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEUTROPHIL CYTOPLASMIC ANTIBODY; PENTRAXIN 3; PREDNISOLONE; PREDNISONE; RITUXIMAB; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; VON WILLEBRAND FACTOR;

ANAPHYLACTOID PURPURA; ANEURYSM; AORTA ARCH SYNDROME; BEHCET DISEASE; BRAIN VASCULITIS; CHILDHOOD DISEASE; CHURG STRAUSS SYNDROME; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE MARKER; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; MICROSCOPIC POLYANGIITIS; MUCOCUTANEOUS LYMPH NODE SYNDROME; PATHOGENESIS; PLASMAPHERESIS; POLYARTERITIS NODOSA; PRIORITY JOURNAL; RECURRENT FEVER; REVIEW; VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 34948820712     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rdc.2007.07.007     Document Type: Review

References (105)

1. Bowyer S.L., Ragsdale C.G., and Sullivan D.B. Factor VIII related antigen and childhood rheumatic diseases. J Rheumatol 16 (1989) 1093-1097
2. Fazzini F., Peri G., Doni A., et al. PTX3 in small-vessel vasculitides: an independent indicator of disease activity produced at sites of inflammation. Arthritis Rheum 44 (2001) 2841
3. Hoffman G.S., Merkel P.A., Brasington R.D., et al. Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis. Arthritis Rheum 50 (2004) 2296
4. Wegener's Granulomatosis Etanercept Trial (WGET) Research Group. Etanercept plus standard therapy for Wegener's granulomatosis. N Engl J Med 352 (2005) 351-361
5. Keogh K.A., Wylam M.E., Stone J.H., and Specks U. Induction of remission by B lymphocyte depletion in 11 patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 52 (2005) 262-268
6. Jennette J.C., and Falk R.J. Do vasculitis categorization systems really matter?. Curr Rheumatol Rep 2 (2000) 430
7. Tesar V., Kazderova M., and Hlavackova L. Rokitansky and his first description of polyarteritis nodosa. J Nephrol 17 (2004) 172
8. Ozen S., Besbas N., Saatci U., et al. Diagnostic criteria for polyarteritis nodosa in childhood. J Pediatr 120 (1992) 206
9. Gardner-Medwin J.M., Dolezalova P., Cummins C., et al. Incidence of Henoch-Schonlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet 360 (2002) 1197
10. Bowyer S., and Roettcher P. Pediatric rheumatology clinic populations in the United States: results of a 3 year survey. Pediatric Rheumatology Database Research Group. J Rheumatol 23 (1996) 1968
11. Huugen D., Tervaert J.W., and Heeringa P. Antineutrophil cytoplasmic autoantibodies and pathophysiology: new insights from animal models. Curr Opin Rheumatol 16 (2004) 4
12. Praprotnik S., Rozman B., Blank M., et al. Pathogenic role of anti-endothelial cell antibodies in systemic vasculitis. Wien Klin Wochenschr 112 (2000) 660
13. Yoshinoya S. [Immune complex and vasculitis]. Nippon Rinsho 52 (1994) 1992-1999 [in Japanese]
14. Ozen S., Anton J., Arisoy N., et al. Juvenile polyarteritis: results of a multicenter survey of 110 children. J Pediatr 145 (2004) 517
15. Brogan P.A., Shah V., Bagga A., et al. T cell Vbeta repertoires in childhood vasculitides. Clin Exp Immunol 131 (2003) 517
16. Kallenberg C.G., and Heeringa P. Pathogenesis of vasculitis. Lupus 7 (1998) 280
17. Jennette J.C. Implications for pathogenesis of patterns of injury in small- and medium-sized-vessel vasculitis. Cleve Clin J Med 69 Suppl 2 (2002) SII33
18. Blanco R., Martinez-Taboada V.M., Rodriguez-Valverde V., et al. Henoch-Schonlein purpura in adulthood and childhood: two different expressions of the same syndrome. Arthritis Rheum 40 (1997) 859
19. Chaussain M., De Boisscai D., Kalifa G., et al. Impairment of lung diffusion capacity in HSP. J Pediatr 121 (1992) 12
20. Dengler L.D., Capparelli E.V., Bastian J.F., et al. Cerebrospinal fluid profile in patients with acute Kawasaki disease. Pediatr Infect Dis J 17 (1998) 478
21. Coppo R., Amore A., and Gianoglio B. Clinical features of Henoch-Schonlein purpura. Italian Group of Renal Immunopathology. Ann Med Interne (Paris) 150 (1999) 143
22. Robson W.L., and Leung A.K. Henoch-Schonlein purpura. Adv Pediatr 41 (1994) 163
23. Saulsbury F.T. Henoch-Schonlein purpura in children. Report of 100 patients and review of the literature. Medicine (Baltimore) 78 (1999) 395
24. Chang W.L., Yang Y.H., Lin Y.T., et al. Gastrointestinal manifestations in Henoch-Schonlein purpura: a review of 261 patients. Acta Paediatr 93 (2004) 1427
25. Gunasekaran T.S., Berman J., and Gonzalez M. Duodenojejunitis: is it idiopathic or is it Henoch-Schonlein purpura without the purpura?. J Pediatr Gastroenterol Nutr 30 (2000) 22
26. Sano H., Izumida M., Shimizu H., et al. Risk factors of renal involvement and significant proteinuria in Henoch-Schonlein purpura. Eur J Pediatr 161 (2002) 196
27. Ronkainen J., Nuutinen M., and Koskimies O. The adult kidney 24 years after childhood Henoch-Schonlein purpura: a retrospective cohort study. Lancet 360 (2002) 666
28. Kawasaki Y., Suzuki J., Sakai N., et al. Clinical and pathological features of children with Henoch-Schoenlein purpura nephritis: risk factors associated with poor prognosis. Clin Nephrol 60 (2003) 153
29. Soylemezoglu O., Ozkaya O., Erbas D., et al. Nitric oxide in Henoch-Schonlein purpura. Scand J Rheumatol 31 (2002) 271
30. Muller D., Greve D., and Eggert P. Early tubular proteinuria and the development of nephritis in Henoch-Schonlein purpura. Pediatr Nephrol 15 (2000) 85
31. Martino F., Agolini D., Tsalikova E., et al. Nailfold capillaroscopy in Henoch-Schonlein purpura: a follow-up study of 31 cases. J Pediatr 141 (2002) 145
32. Saraclar Y., Tinaztepe K., Adalioglu G., et al. Acute hemorrhagic edema of infancy (AHEI)-a variant of Henoch-Schonlein purpura or a distinct clinical entity?. J Allergy Clin Immunol 86 (1990) 473
33. Calabrese L.H., Michel B.A., Bloch D.A., et al. The American College of Rheumatology 1990 criteria for the classification of hypersensitivity vasculitis. Arthritis Rheum 33 (1990) 1108
34. Sundel R., and Szer I. Vasculitis in childhood. Rheum Dis Clin North Am 28 (2002) 625
35. Flynn J.T., Smoyer W.E., Bunchman T.E., et al. Treatment of Henoch-Schonlein purpura glomerulonephritis in children with high-dose corticosteroids plus oral cyclophosphamide. Am J Nephrol 21 (2001) 128
36. Newburger J.W., Takahashi M., Burns J.C., et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 315 (1986) 341
37. Newburger J.W., Taubert K.A., Shulman S.T., et al. Summary and abstracts of the Seventh International Kawasaki Disease Symposium: December 4-7, 2001, Hakone, Japan. Pediatr Res 53 (2003) 153
38. Newburger J.W., Takahashi M., Gerber M.A., et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 114 (2004) 1708
39. Rowley A.H., Shulman S.T., Spike B.T., et al. Oligoclonal IgA response in the vascular wall in acute Kawasaki disease. J Immunol 166 (2001) 1334
40. Rowley A.H., Baker S.C., Shulman S.T., et al. Detection of antigen in bronchial epithelium and macrophages in acute Kawasaki disease by use of synthetic antibody. J Infect Dis 190 (2004) 856
41. Yanagawa H., Yashiro M., Nakamura Y., et al. Nationwide surveillance of Kawasaki disease in Japan, 1984 to 1993. Pediatr Infect Dis J 14 (1995) 69
42. Rowley A.H., Wolinsky S.M., Relman D.A., et al. Search for highly conserved viral and bacterial nucleic acid sequences corresponding to an etiologic agent of Kawasaki disease. Pediatr Res 36 (1994) 567
43. Kawasaki T. [Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children]. Arerugi 16 (1967) 178 [in Japanese]
44. Burns J.C., Mason W.H., Glode M.P., et al. Clinical and epidemiologic characteristics of patients referred for evaluation of possible Kawasaki disease. United States Multicenter Kawasaki Disease Study Group. J Pediatr 118 (1991) 680
45. Sundel R.P. Update on the treatment of Kawasaki disease in childhood. Curr Rheumatol Rep 4 (2002) 474
46. Leung D.Y. The potential role of cytokine-mediated vascular endothelial activation in the pathogenesis of Kawasaki disease. Acta Paediatr Jpn 33 (1991) 739
47. Smith L.B., Newburger J.W., and Burns J.C. Kawasaki syndrome and the eye. Pediatr Infect Dis J 8 (1989) 116
48. April M.M., Burns J.C., Newburger J.W., et al. Kawasaki disease and cervical adenopathy. Arch Otolaryngol Head Neck Surg 115 (1989) 512
49. Joffe A., Kabani A., and Jadavji T. Atypical and complicated Kawasaki disease in infants. Do we need criteria?. West J Med 162 (1995) 322
50. Yanagawa H., Tuohong Z., Oki I., et al. Effects of gamma-globulin on the cardiac sequelae of Kawasaki disease. Pediatr Cardiol 20 (1999) 248
51. Burns J.C., Capparelli E.V., Brown J.A., et al. Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. US/Canadian Kawasaki Syndrome Study Group. Pediatr Infect Dis J 17 (1998) 1144
52. Wen Y.K., Yang Y., and Chang C.C. Cerebral vasculitis and intracerebral hemorrhage in Henoch-Schonlein purpura treated with plasmapheresis. Pediatr Nephrol 20 (2005) 223-225
53. Yanagihara R., and Todd J.K. Acute febrile mucocutaneous lymph node syndrome. Am J Dis Child 134 (1980) 603
54. Beiser A.S., Takahashi M., Baker A.L., et al. A predictive instrument for coronary artery aneurysms in Kawasaki disease. US Multicenter Kawasaki Disease Study Group. Am J Cardiol 81 (1998) 1116
55. Kusakawa S., and Tatara K. Efficacies and risks of aspirin in the treatment of the Kawasaki disease. Prog Clin Biol Res 250 (1987) 401
56. Furusho K., Kamiya T., Nakano H., et al. High-dose intravenous gammaglobulin for Kawasaki disease. Lancet 2 (1984) 1055
57. Hsieh K.S., Weng K.P., Lin C.C., et al. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited. Pediatrics 114 (2004) e689
58. Kato H., Koike S., Tanaka C., et al. Coronary heart disease in children with Kawasaki disease. Jpn Circ J 43 (1979) 469
59. Shinohara M., Sone K., Tomomasa T., et al. Corticosteroids in the treatment of the acute phase of Kawasaki disease. J Pediatr 135 (1999) 465
60. Okada Y., Shinohara M., Kobayashi T., et al. Effect of corticosteroids in addition to intravenous gamma globulin therapy on serum cytokine levels in the acute phase of Kawasaki disease in children. J Pediatr 143 (2003) 363
61. Sundel R.P., Baker A.L., Fulton D.R., et al. Corticosteroids in the initial treatment of Kawasaki disease: report of a randomized trial. J Pediatr 142 (2003) 611
62. Burns J.C., and Glode M.P. Kawasaki syndrome. Lancet 364 (2004) 533
63. Newburger J.W., Takahashi M., Beiser A.S., et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 324 (1991) 1633
64. Weiss J.E., Eberhard B.A., Chowdhury D., et al. Infliximab as a novel therapy for refractory Kawasaki disease. J Rheumatol 31 (2004) 808
65. Fukushige J., Takahashi N., Ueda K., et al. Long-term outcome of coronary abnormalities in patients after Kawasaki disease. Pediatr Cardiol 17 (1996) 71
66. Dhillon R., Clarkson P., Donald A.E., et al. Endothelial dysfunction late after Kawasaki disease. Circulation 94 (1996) 2103
67. McConnell M.E., Hannon D.W., Steed R.D., et al. Fatal obliterative coronary vasculitis in Kawasaki disease. J Pediatr 133 (1998) 259
68. Tomita S., Chung K., Mas M., et al. Peripheral gangrene associated with Kawasaki disease. Clin Infect Dis 14 (1992) 121
69. Williams R.V., Wilke V.M., Tani L.Y., et al. Does abciximab enhance regression of coronary aneurysms resulting from Kawasaki disease?. Pediatrics 109 (2002) E4
70. Nakamura Y., Yanagawa H., Harada K., et al. Mortality among persons with a history of Kawasaki disease in Japan: the fifth look. Arch Pediatr Adolesc Med 156 (2002) 162
71. Baker A.L., Gauvreau K., Newburger J.W., et al. Physical and psychosocial health in children who have had Kawasaki disease. Pediatrics 111 (2003) 579
72. Blanco R., Martinez-Taboada V.M., Rodriguez-Valverde V., et al. Cutaneous vasculitis in children and adults. Associated diseases and etiologic factors in 303 patients. Medicine (Baltimore) 77 (1998) 403
73. Ozen S., Saatci U., Balkanci F., et al. Familial Mediterranean fever and polyarteritis nodosa. Scand J Rheumatol 21 (1992) 312
74. Fink C.W. Vasculitis. Pediatr Clin North Am 33 (1986) 1203
75. David J., Ansell B.M., and Woo P. Polyarteritis nodosa associated with streptococcus. Arch Dis Child 69 (1993) 685
76. Sheth A.P., Olson J.C., and Esterly N.B. Cutaneous polyarteritis nodosa of childhood. J Am Acad Dermatol 31 (1994) 561
77. Garcia-Porrua C., and Gonzalez-Gay M.A. Successful response to infliximab in a patient with undifferentiated spondyloarthropathy coexisting with polyarteritis nodosa-like cutaneous vasculitis. Clin Exp Rheumatol 21 (2003) S138
78. Mouthon L., Le Toumelin P., Andre M.H., et al. Polyarteritis nodosa and Churg-Strauss angiitis: characteristics and outcome in 38 patients over 65 years. Medicine (Baltimore) 81 (2002) 27
79. Brogan P.A., and Dillon M.J. Vasculitis from the pediatric perspective. Curr Rheumatol Rep 2 (2000) 411
80. Noris M. Pathogenesis of Takayasu's arteritis. J Nephrol 14 (2001) 506
81. Seo P., and Stone J.H. Large-vessel vasculitis. Arthritis Rheum 51 (2004) 128
82. Kimura A., Ota M., Katsuyama Y., et al. Mapping of the HLA-linked genes controlling the susceptibility to Takayasu's arteritis. Int J Cardiol 75 Suppl 1 (2000) S105
83. Yalcindag A., and Sundel R. Vasculitis in childhood. Curr Opin Rheumatol 13 (2001) 422
84. Kerr G.S., Hallahan C.W., Giordano J., et al. Takayasu arteritis. Ann Intern Med 120 (1994) 919
85. Tso E., Flamm S.D., White R.D., et al. Takayasu arteritis: utility and limitations of magnetic resonance imaging in diagnosis and treatment. Arthritis Rheum 46 (2002) 1634
86. Seo J.W., Park I.A., Yoon D.H., et al. Thoracic aortic aneurysm associated with aortitis-case reports and histological review. J Korean Med Sci 6 (1991) 75
87. Calabrese L. Primary angiitis of the central nervous system: the penumbra of vasculitis. J Rheumatol 28 (2001) 465
88. Gallagher K.T., Shaham B., Reiff A., et al. Primary angiitis of the central nervous system in children: 5 cases. J Rheumatol 28 (2001) 616
89. Benseler S., and Schneider R. Central nervous system vasculitis in children. Curr Opin Rheumatol 16 (2004) 43
90. Rottem M., Fauci A.S., Hallahan C.W., et al. Wegener granulomatosis in children and adolescents: clinical presentation and outcome. J Pediatr 122 (1993) 26
91. Langford C.A., Sneller M.C., Hallahan C.W., et al. Clinical features and therapeutic management of subglottic stenosis in patients with Wegener's granulomatosis. Arthritis Rheum 39 (1996) 1754
92. Yu F., Zhao M.H., Huang J.P., et al. [Clinical and pathological features of anti-neutrophil cytoplasm antibody associated systemic vasculitis in children]. Zhonghua Er Ke Za Zhi 41 (2003) 831 [in Japanese]
93. Langford C.A., and Sneller M.C. Update on the diagnosis and treatment of Wegener's granulomatosis. Adv Intern Med 46 (2001) 177
94. Langford C.A., Talar-Williams C., Barron K.S., et al. A staged approach to the treatment of Wegener's granulomatosis: induction of remission with glucocorticoids and daily cyclophosphamide switching to methotrexate for remission maintenance. Arthritis Rheum 42 (1999) 2666
95. Heeringa P., and Tervaert J.W. Pathophysiology of ANCA-associated vasculitides: are ANCA really pathogenic?. Kidney Int 65 (2004) 1564
96. Sanders J.S., Slot M.C., and Stegeman C.A. Maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 349 (2003) 2072
97. Weyand C.M., and Goronzy J.J. Medium- and large-vessel vasculitis. N Engl J Med 349 (2003) 160
98. Eldem B., Onur C., and Ozen S. Clinical features of pediatric Behcet's disease. J Pediatr Ophthalmol Strabismus 35 (1998) 159
99. Uziel Y., Brik R., Padeh S., et al. Juvenile Behcet's disease in Israel. The Pediatric Rheumatology Study Group of Israel. Clin Exp Rheumatol 16 (1998) 502
100. Park S.H., Park K.S., Seo Y.I., et al. Association of MICA polymorphism with HLA-B51 and disease severity in Korean patients with Behcet's disease. J Korean Med Sci 17 (2002) 366
101. Sakane T., and Takeno M. Current therapy in Behcet's disease. Skin Therapy Lett 5 (2000) 3
102. Ozen S. Vasculopathy, Behcet's syndrome, and familial Mediterranean fever. Curr Opin Rheumatol 11 (1999) 393
103. Lamprecht P., Moosig F., Adam-Klages S., et al. Small vessel vasculitis and relapsing panniculitis in tumour necrosis factor receptor associated periodic syndrome (TRAPS). Ann Rheum Dis 63 (2004) 1518
104. Hunder GG, Wilking AP. Classification of the vasculitides in children. UptoDate, 2005. Available at: http://www.utdol.com/application/search.asp. Accessed February 14, 2005.
105. Centers for Disease Control. Revised diagnostic criteria for Kawasaki disease. MMWR 39 No. 44-13 (1990) 27-28